Merck announced the completion of its $ 17 billion acquisition of Sigma-Aldrich, creating one of the leaders in the $ 130 billion global industry. The completion follows last week’s approval from the European Commission, which was the final antitrust condition required to close the Sigma-Al ... more
Heinrich Emanuel Merck Award 2012 granted to Professor Aaron Wheeler
Merck announced that the 2012 Heinrich Emanuel Merck Award for Analytical Science will be given to Professor Wheeler from the University of Toronto for his development of a digital microfluidic method for the extraction and quantification of estrogen in 1-microliter samples of breast tissue homogenate, whole blood and serum. This method may be broadly applicable for diagnostics requiring frequent analysis of hormones in clinical samples, which are important markers for example in infertility or cancer. The award, endowed with € 15,000, will be presented to Professor Wheeler at Merck Millipore’s Technology Exposition in Bedford, Massachusetts, USA, on October 17, 2012.
“Professor Wheeler`s development of new analytical methods using digital microfluidic technology to overcome the limitations of conventional techniques in the extraction and quantification of estrogen is an outstanding scientific achievement with significant societal impact, for example in breast cancer diagnosis,” explained Professor Reinhard Niessner (Technical University of Munich, Germany), the head of the international jury for the Heinrich Emanuel Merck Award.
“By selecting Aaron Wheeler, we are recognizing a talented and very successful scientist. We are looking forward to his award lecture in October,” said Dr. Thomas Geelhaar, Chief Technology Officer Chemicals at Merck. “Thanks to his groundbreaking scientific approach, Professor Wheeler has helped to achieve tremendous advances in the research field of hormone analysis.”
Aaron R. Wheeler (37) is an Associate Professor at the University of Toronto, Department of Chemistry. The Wheeler research group is developing hybrid methods that rely on the unique advantages of microchannels and digital microfluidics for applications in the areas of chemistry, biology, and medicine.
As part of the global strategic alliance between Merck and Pfizer to jointly develop and commercialize avelumab, an investigational immune checkpoint inhibitor, the companies have announced that they have a collaboration agreement in place with Dako, an Agilent Technologies company, for the ... more
Merck announced that the European Commission has approved its planned acquisition of U.S.-based life science company Sigma-Aldrich. The EU clearance, which is subject to certain conditions, follows the recent antitrust approvals in Japan (JFTC) and by the Chinese Ministry of Commerce (MOFCO ... more
The Scepter™, the industry's first handheld, automated cell counter represents a breakthrough for life science researchers more
To keep pace with the daily needs of your lab, you know it's crucial to have consistent pure water quality as well as the volumes of water you require more
This unique fully-embedded water purification system software has been developed especially for the pharmaceutical, biotech and contract labs more
- 1Schleicher & Schuell has been purchased by Whatman plc
- 2Argonne’s lithium-ion battery technology to be commercialized by BASF
- 3LGC rebrands reference standards
- 4Endress+Hauser Set for Complete Acquisition of Analytik Jena
- 5Agilent Technologies completes acquisition of Seahorse Bioscience
- 6Device combines power of mass spectrometry, microscopy
- 7Researchers design and patent graphene biosensors
- 8Thermo Fisher Scientific Scientist Dr. Alexander Makarov Receives Inaugural HUPO Science and Technology Award
- 9Waters Corporation Announces Christopher J. O'Connell as Chief Executive Officer
- 10Bruker announces Rene Lenggenhager as BioSpin Group president